Filtering Race Out of GFR Calculation

References

1. 1.↵
   1. Gutiérrez OM,
   2. Sang Y,
   3. Grams ME

   , Chronic Kidney Disease Prognosis Consortiumet al. Association of estimated GFR calculated using race-free equations with kidney failure and mortality by Black vs non-Black race. JAMA 2022;327:2306–16.

   OpenUrlPubMed
2. 2.↵
   1. Levey AS,
   2. Stevens LA,
   3. Schmid CH

   , CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604–12.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Ahmed S,
   2. Nutt CT,
   3. Eneanya ND,
   4. et al

   . Examining the potential impact of race multiplier utilization in estimated glomerular filtration rate calculation on African American care outcomes. J Gen Intern Med 2020;36:464–71.

   OpenUrlPubMed
4. 4.↵
   USRDS. United States Renal Data System. 2015 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda, MD: 2015. 2015.
5. 5.↵
   1. Sood A,
   2. Abdullah NM,
   3. Abdollah F,
   4. et al

   . Rates of kidney transplantation from living and deceased donors for Blacks and Whites in the United States, 1998 to 2011. JAMA Intern Med 2015;175:1716–8.

   OpenUrlPubMed
6. 6.↵
   1. Purnell TS,
   2. Luo X,
   3. Cooper LA,
   4. et al

   . Association of race and ethnicity with live donor kidney transplantation in the United States From 1995 to 2014. JAMA 2018;319:49–61.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Levey AS,
   2. Greene T,
   3. Beck GJ,
   4. et al

   . Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. J Am Soc Nephrol 1999;10:2426–39.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Jain A,
   2. Brooks JR,
   3. Alford CC,
   4. et al

   . Awareness of racial and ethnic bias and potential solutions to address bias with use of health care algorithms. JAMA Health Forum 2023;4:e231197.

   OpenUrl
9. 9.↵
   1. Shlipak MG,
   2. Matsushita K,
   3. Ärnlöv J

   , CKD Prognosis Consortiumet al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 2013;369:932–43.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Peralta CA,
    2. Shlipak MG,
    3. Judd S,
    4. et al

    . Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA 2011;305:1545–52.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    National Kidney Foundation, American Society of Nephrology. Removing race from estimates of kidney function. March 9, 2021 (https://www.asn-online.org/about/press/releases/ASN_PR_20210309_Press_release_NKF_A.pdf. opens in new tab).
12. 12.↵
    1. Smith P,
    2. Castelli G

    . The Priority Updates from the Research Literature (PURLs) Methodology. J Am Board Fam Med 2024;37:799–802.

    OpenUrlFREE Full Text